Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases

Overview

cited authors

Modica, Renee F.; Thatayatikom, Akaluck; Bell-Brunson, Denise H.; Elder, Melissa E.

authors

Thatayatikom, Akaluck, MD

Publication Date

March 27, 2023

webpage

Web of Science

published in

CLINICAL RHEUMATOLOGY Journal

Research

keywords

Bortezomib
Central nervous system (CNS) lupus
Neuropsychiatric systemic lupus erythematosus (NPLSE)
Pediatric
Plasma cell
Psychosis

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.